Products for Research Use Only
RegisterLogin

JAK-IN-26

CAT: 0804-HY-153701-01Size: 10 mM - 1 mLDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-153701-01Size:10 mM - 1 mL
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
JAK-IN-26 (Compound 2) is a JAK inhibitor. JAK-IN-26 inhibits IFN-α2b induced p-STAT3 in Jurkat cells (IC50: 17.2 nM) . JAK-IN-26 has superior pharmacokinetic properties[1].
CAS Number
2417134-93-9
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jak-in-26.html
Purity
99.56
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1CC1)NC2=NC=C(C(NC3=CC=CC(C4=NN(C)C=N4)=C3OC)=C2)C(CC)=O
Molecular Formula
C22H24N6O3
Molecular Weight
420.46
References & Citations
[1]Zhou M, et al. Pyridine derivatives as TYK2 kinase inhibitors and preparation thereof. China, CN113563309 A 2021-10-29.|[2]Zhou Mengguang. Pyridine derivative and preparation method and application thereof. Patent. CN113563309.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-111471JAK-IN-5
HY-18301-01JAK-IN-35
HY-151262-01JAK-IN-23
HY-157011JAK-IN-33
HY-143444-01JAK-IN-20
HY-111749JAK-IN-4
HY-144057JAK-IN-17
HY-14986JAK-IN-32
HY-46262JAK-IN-15
HY-139807-01JAK-IN-14

Alternative Products

CatalogName
GTR19231163-01JAK-IN-26
M26394-01JAK-IN-11
BA4919-10JAK-IN-14
BA4937-1JAK-IN-30
BA4922-1JAK-IN-24
JDC67353-01JAK-IN-1
T210131-01JAK-IN-37
T79222-01JAK-IN-29
T73250-01JAK-IN-17
MBS3844679-01JAK-IN-4

Popular Products